EU leaders avoid controversial options as they discuss defence spending boost
- 78
The Commission estimates that the EU needs to invest €500 billion in the sector over the coming decade so that it can continue to ...
Euronews

Welcome to the official Euronews YouTube channel!
Around the clock, our team of 500 journalists of more than 30 different nationalities gathers news with impartial perspective, beyond the headlines content and voices from across Europe and the world. Our YouTube channel has all this and more, bringing you selected and original content from the world's most trusted news source.
Our mission is to empower people to form their own opinion. We trust in people’s intelligence and ability to make up their own mind and seek to provide our audience with the greatest diversity of viewpoints through journalism that is unapologetically impartial. We don’t trade in bias and outrage, we focus on facts, ideas, and solutions. We believe all views matter.
Euronews was born out of a will to create a strong independent European news channel in 1993. As the only international news media with a European perspective, Euronews is where the world turns to hear what Europe has to say.
Check us out on ⬇️
Lastest news
- ROSEN, A LEADING LAW FIRM, Encourages Zynex, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - ZYXI
- ROSEN, A GLOBAL INVESTOR RIGHTS LAW FIRM, Encourages NAPCO Security Technologies, Inc. Investors to Inquire About Securities Class Action Investigation - NSSC
- New Patient-Reported Outcomes from UGN-102 Clinical Trials Show the Investigational Treatment Did Not Adversely Affect Functionality, Symptom Burden, and Quality of Life in Patients with LG-IR-NMIBC
- New Long-Term Follow-Up Data from OPTIMA II Study of UGN-102 Demonstrates Median Duration of Response of Two Years in Patients with LG-IR-NMIBC
- Revolution Medicines Presents Initial Data from Zoldonrasib (RMC-9805) Study in Patients with KRAS G12D Mutant Non-Small Cell Lung Cancer at the 2025 AACR Annual Meeting
- GERN Deadline: Rosen Law Firm Urges Geron Corporation (NASDAQ: GERN) Stockholders to Contact the Firm for Information About Their Rights